(NASDAQ: TECX) (“Tectonic”) a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled ...

Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...

Highlighted text has been updated as of October 22, 2024. The RELAX-AHF-2 trial failed to show that serelaxin was superior to placebo at improving outcomes in acute heart failure. Patients were ...

TX45 is an Fc-relaxin fusion molecule targeting the RXFP1 receptor, offering potential therapeutic benefits for hypertension and heart failure with preserved ejection fraction (HFpEF). Tectonic ...

AHA 2024 Presentation Details (being held in Chicago, IL, Nov 16-18, 2024): ...

Patient enrollment in the Phase 1b hemodynamic trial remains ahead of expectation, with topline results now expected in late Q1’2025 or early ...

How do you find the right stocks to buy? It’s a simple question, but the answer can be challenging. Thankfully, there are ...

Tectonic announced topline results from the study on September 19, 2024. Tectonic’s lead program, TX45, is an Fc-relaxin fusion protein with optimized pharmacokinetics and biophysical properties ...

Hip pain in women can stem from hormonal changes, fractures, infections, and more. Pain can range from mild to severe, ...

Gait changes. Fallen arches. A whole new shoe size. Many women experience these transformations during pregnancy, but the phenomenon is rarely discussed outside the mom group text.

I definitely felt less wobbly. But relaxin stays elevated if you're breastfeeding, which I was. The hormone is not at pregnancy levels, but during the postpartum period, it’s not back to ...